Please provide your email address to receive an email when new articles are posted on . Otezla is now available in the U.S. to treat children and adolescents with moderate to severe plaque psoriasis.
PDE4 Inhibitor Commercial success: ZORYVE achieved $166 million in revenue during 2024, representing a remarkable 471% ...
Image above: scene from an Otezla commercial. Amgen was up slightly in earnings during the third quarter and Pfizer was way, way down. Here are highlights of both pharma companies’ earnings reports, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback